Joint association of leukocyte telomere length and muscle mass with mortality: a longitudinal nationwide population-based study

Telomere and skeletal muscle mass are independent risk factors for mortality, but their joint effects have not been fully elucidated. Accelerated aging and unhealthy skeletal muscle are growing public health concerns in an aging society. We sought to investigate the joint effects of leukocyte telomere length (LTL) and muscle mass with mortality in the National Health and Nutrition Examination Survey (NHANES) 1999–2002. Telomere length was determined by quantitative polymerase chain reaction (qPCR), and skeletal muscle mass was measured by dual-energy X-ray absorptiometry (DXA), and expressed as limb skeletal muscle mass index (ASMI). The Cox proportional hazards regression model was used to analyze the association between it and all-cause mortality. A total of 4668 individuals (mean age 48.43 years, female 48.9%) were included. During a median follow-up of 16.92 years, there were 1,138 deaths (cardiovascular disease,288). 2,833 (60.7%) had neither lower LTL nor lower ASMI, 1,226 (26.3%) had only lower LTL, 364 (7.8%) had only lower ASMI, and 245 (5.2%) had both lower LTL and lower ASMI. Compared to the LTL normal /ASMI normal group, the LTL lower /ASMI normal , LTL normal /ASMI lower , and LTL lower /ASMI lower groups demonstrated increased all-cause mortality with adjusted hazard ratios (HRs) of 1.31 (95% confidence interval [CI]: 1.08, 1.58), 1.79 (95% CI: 1.44, 2.23), and 1.64 (95% CI: 1.32, 2.04), respectively. Similarly, participants with LTL lower and/or ASMI lower had a higher risk of cardiovascular disease mortality (HRs, 1.56–1.99) than those with LTL normal /ASMI normal . Further stratified analyses showed that the coexistence of LTL lower and ASMI lower additively increased the risk of all-cause mortality in younger participants (< 60 years) (HR 2.38, 95% CI: 1.22–4.65) and in women (HR 1.94, 95% CI: 1.28–2.96). In contrast, among older participants and men with LTL normal / ASMI lower , the risk of all-cause mortality was higher than among those with LTL lower /ASMI lower . Low telomere length and low skeletal muscle mass were jointly associated with greater risk of all-cause mortality, especially among younger individuals and women.

Authors

Institutions

Publication Details

Journal
Nutrition & Metabolism
Published
2026-09-25
DOI
https://doi.org/10.1186/s12986-026-01199-w
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Joint association of leukocyte telomere length and muscle mass with mortality: a longitudinal nationwide population-based study

Lingzhi Chen, Tao Chen, Xuan Li, Qinghe Hu et al.
Nutrition & Metabolism
Telomeres, Telomerase, and Senescence
article

Joint association of leukocyte telomere length and muscle mass with mortality: a longitudinal nationwide population-based study

Lingzhi Chen, Tao Chen, Xuan Li, Qinghe Hu, Jiwen Ge, Yajie Dai, Chaoqun Zhao
article en

Abstract

Telomere and skeletal muscle mass are independent risk factors for mortality, but their joint effects have not been fully elucidated. Accelerated aging and unhealthy skeletal muscle are growing public health concerns in an aging society. We sought to investigate the joint effects of leukocyte telomere length (LTL) and muscle mass with mortality in the National Health and Nutrition Examination Survey (NHANES) 1999–2002. Telomere length was determined by quantitative polymerase chain reaction (qPCR), and skeletal muscle mass was measured by dual-energy X-ray absorptiometry (DXA), and expressed as limb skeletal muscle mass index (ASMI). The Cox proportional hazards regression model was used to analyze the association between it and all-cause mortality. A total of 4668 individuals (mean age 48.43 years, female 48.9%) were included. During a median follow-up of 16.92 years, there were 1,138 deaths (cardiovascular disease,288). 2,833 (60.7%) had neither lower LTL nor lower ASMI, 1,226 (26.3%) had only lower LTL, 364 (7.8%) had only lower ASMI, and 245 (5.2%) had both lower LTL and lower ASMI. Compared to the LTL normal /ASMI normal group, the LTL lower /ASMI normal , LTL normal /ASMI lower , and LTL lower /ASMI lower groups demonstrated increased all-cause mortality with adjusted hazard ratios (HRs) of 1.31 (95% confidence interval [CI]: 1.08, 1.58), 1.79 (95% CI: 1.44, 2.23), and 1.64 (95% CI: 1.32, 2.04), respectively. Similarly, participants with LTL lower and/or ASMI lower had a higher risk of cardiovascular disease mortality (HRs, 1.56–1.99) than those with LTL normal /ASMI normal . Further stratified analyses showed that the coexistence of LTL lower and ASMI lower additively increased the risk of all-cause mortality in younger participants (< 60 years) (HR 2.38, 95% CI: 1.22–4.65) and in women (HR 1.94, 95% CI: 1.28–2.96). In contrast, among older participants and men with LTL normal / ASMI lower , the risk of all-cause mortality was higher than among those with LTL lower /ASMI lower . Low telomere length and low skeletal muscle mass were jointly associated with greater risk of all-cause mortality, especially among younger individuals and women.

Nutrition & Metabolism
Affiliated Hospital of Jining Medical University (CN), Jining Medical University (CN)
Good health and well-being
Openalex Percentile: Top 11%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.